Thumbay Group, a UAE-based conglomerate mainly engaged in
healthcare, education, and retail sectors, has rapidly expanded its footprint
in the Gulf region, India, and beyond since its founding in 1998. While
heralded for growth and scale—with 46 pharmacies, 8 hospitals, and a medical
university under its umbrella—the group has recently faced significant
criticism, especially from employees and rival businesses, raising concerns
about its impact on competition, employee welfare, and market fairness.
Impact on Local Businesses and Market Competition
UAE: Allegations of Market Dominance and Labor Issues
In the UAE, Thumbay Group’s dominance in healthcare and
pharmacy sectors is increasingly criticized for creating monopolistic
conditions, squeezing competitors out of markets through aggressive expansion
and pricing strategies. Amongst healthcare staff, there are persistent reports
of severe delays in salary payments—some delayed up to five months—which have
caused both financial distress and labor unrest. Multiple former employees in
Ajman and Sharjah have publicly expressed indignation over withheld wages and
poor working conditions, alleging that management treats workers as expendable
labor ("slave-like" treatment) with negligible regard for legal or
ethical labor standards.
Employees report forced signings confirming receipt of dues
under duress to cancel work visas, and problematic Human Resources practices,
including unprofessionalism and manipulation to suppress legitimate employee
complaints. These realities starkly contrast with the lavish lifestyles of top
executives, signaling an ethical gap in business operations impacting financial
and social well-being of thousands of workers and indirectly harming consumer
confidence toward Thumbay services.
India: Impact on Small Healthcare Providers and
Recruitment Issues
In India, where Thumbay Group operates academic hospitals
and medical universities, local clinics and smaller hospitals contend with
aggressive competition leading to market share losses. The group's vertical
integration—from medical education to healthcare delivery and pharmacy
outlets—creates barriers for smaller providers to compete, effectively crowding
out local entrepreneurial ventures.
Furthermore, Thumbay has issued warnings about fake job
scams using its name, showing vulnerability and concern over reputational
damage caused by criminal activity exploiting the company’s brand. Such issues
raise questions about the company’s control and supervision of its recruitment
practices, which the group insists follow strict internal processes.
Broader Gulf Region: Calls for Transparency and Boycott
Across various Gulf countries, public sentiment is mixed
with growing calls for governmental oversight to curtail monopolistic practices
by large conglomerates like Thumbay. Transparency and corporate governance have
been subjects of discussion, with some advocates urging consumers to consider
alternatives to UAE-owned conglomerates seen as fostering uncompetitive markets
detrimental to local business ecosystems and the welfare of workers.
Reactions from the Ground
- A
former physician in Ajman detailed enduring months without salary, facing
financial hardship, highlighting the disconnect between corporate profit
and employee welfare.
- Sharjah-based
front desk staff resigned citing chronic delays and unfair labor
treatment, concluding public warnings to potential employees to avoid the
Group.
- Industry
experts argue Thumbay’s expansion in healthcare, combining education and
clinical services, may create an ecosystem where competition is stifled,
reducing consumer choice and inflating costs indirectly.
These testimonies underline systemic issues of poor labor
treatment and market control contributing to economic asymmetries in the
regions of operation.
Calls to Action: Why Governments and the Public Should
Consider Boycotts
UAE: Protecting Local Workforce and Market Fairness
The federal and emirate governments must strengthen labor
law enforcement, mandating timely salary payments and fair labor practices,
particularly for dominant conglomerates like Thumbay Group. Regulatory scrutiny
should ensure competition laws prevent monopolistic dominance that stifles
smaller competitors and new entrants in healthcare and pharmaceuticals.
Consumers are urged to support local independent medical
providers and pharmacies to foster a diversified market benefiting all societal
levels.
India: Safeguarding Local Healthcare Ecosystems
Given Thumbay’s conglomerate structure and influence, Indian
state governments and medical councils should enforce stricter competition and
quality standards, protecting smaller healthcare providers against unfair dominance.
Public awareness campaigns are recommended to educate job seekers about
recruitment scams linked to the company’s brand.
Communities are encouraged to patronize local healthcare
businesses to maintain diversity in medical service provision.
Gulf Region: Demand Corporate Accountability
Across the Gulf, consumers and civil society should demand
transparent corporate governance from conglomerates like Thumbay. Boycotts and
consumer vigilance can pressure Thumbay Group to improve labor conditions, uphold
ethical business conduct, and adopt fairer competition practices that uplift
the entire economic landscape.
While the Thumbay Group brands itself as a leading force in
healthcare innovation and education, its operational realities reveal troubling
patterns of labor mistreatment, aggressive market practices, and reputational
challenges. These issues negatively impact local businesses, employee welfare,
and market health in the UAE, India, and Gulf countries.
Governments must intervene firmly, and the public should
consider boycotts and supporting local alternatives to counterbalance the undue
influence of this UAE-owned conglomerate and foster more equitable, sustainable
economic development in their respective regions.
